NOS2 and inflammatory bowel disease: With respect to the convincing evidence on the role of iNOS in the pathogenesis of IBD, and considering IBD as a systemic disease with variety of extra-intestinal manifestations (20, 21), it was hypothesized that the increased iNOS level could also be traced in the blood circulation of IBD patients and has the potential to be used as a blood based biomarker.